Researchers at Harvard University and the Wyss Institute are developing an injectable biomaterial that forms a tiny scaffold in the body which can be used to re-program cells and trigger an immune response to fight cancer and infectious diseases. Ben Gruber Reports.
01:41
02:00
01:08
02:15
01:52
01:17
01:22
01:52
02:54
01:15
02:11
01:38
00:43
01:42
01:41
02:03
01:48
01:28
02:16
01:34